Latest / All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier

Drug Survival of Omalizumab
In this episode of the Urticaria podcast series, Prof. Torsten Zuberbier speaks with Reineke Soegiharto, PhD candidate and dermatology resident from UMC Utrecht, about the international UCARE study DRUSO-CU, which investigated the drug survival of omalizumab in chronic urticaria.
They discuss:
🔹 What does “drug survival” mean and why is it a meaningful real-world outcome measure?
🔹 How long do patients with chronic urticaria typically remain on omalizumab therapy?
🔹 Why do patients discontinue treatment — and what does this say about effectiveness and safety?
🔹 How do early treatment response…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.